Osler Diagnostics
Industry
- In Vitro Diagnostics
See more in Biomedtracker
Latest on Osler Diagnostics
In Vivo
• By Deanna Kamienski and Maureen Riordan
Biopharma Financing Biopharma financings during the fourth quarter of 2022 totaled $17.5bn from 282 deals; of those, 53 financings met or exceeded the $100m mark. Overall, follow on public offerings (
Medtech Insight
• By Barnaby Pickering
Osler Diagnostics is trying to change point-of-care diagnostics in the wake of the Theranos scandal. The criminal trials Elizabeth Holmes and Sunny Balwani, Theranos' CEO and COO, respectively, have